rofecoxib has been researched along with DDD MPGNII in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitahara, M | 1 |
| Eitner, F | 1 |
| Ostendorf, T | 1 |
| Kunter, U | 1 |
| Janssen, U | 1 |
| Westenfeld, R | 1 |
| Matsui, K | 1 |
| Kerjaschki, D | 1 |
| Floege, J | 1 |
1 other study available for rofecoxib and DDD MPGNII
| Article | Year |
|---|---|
Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis.
Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Glomerular Mesangium; Glomerulonephritis, Membranopro | 2002 |